Concepedia

Acid-reducing Agent Interactions

Acid-Reducing Agent Interactions is a pharmacological phenomenon in which the co-administration of acid-reducing agents, such as proton pump inhibitors or histamine-2 receptor antagonists, alters the absorption, bioavailability, or efficacy of hepatitis medications by modifying gastric pH.

39

Publications

2.1K

Citations

193

Authors

107

Institutions

Publications per year

2017–2026

8

Parents

Publications

39

Synthesis of highly stable dispersions of nanosized copper particles using l-ascorbic acid

Jing Xiong, Ye Wang, Qunji Xue et al. · Green Chemistry · 2011 · 493 citations

, , +15

Influence of Speciation of Aqueous HAuCl<sub>4</sub> on the Synthesis, Structure, and Property of Au Colloids

Shu Wang, Kun Qian, XingZhen Bi et al. · The Journal of Physical Chemistry C · 2009 · 192 citations

, , +17

Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development

Gillian S. Smelick, Timothy P. Heffron, Laura Chu et al. · Molecular Pharmaceutics · 2013 · 188 citations

, , +14

Reaction of ascorbic acid with S-nitrosothiols: clear evidence for two distinct reaction pathways

Anthony J. Holmes, D. Lyn H. Williams · Journal of the Chemical Society Perkin Transactions 2 · 2000 · 106 citations

, , +13

Reductive <i>C</i>-alkylation

Basil V. Gregorovich, Katherine S. Y. Liang, D. M. Clugston et al. · Canadian Journal of Chemistry · 1968 · 93 citations

, , +8

1–5 of 39

Authors

193

  1. JA
    Joseph A. Ware

    Pfizer (United States), United States

    2 publications · 211 citations

    2

    h-index

  2. LZ
    Leslie Z. Benet

    University of California, San Francisco, United States

    2 publications · 211 citations

    2

    h-index

  3. GS
    Gillian S. Smelick

    Stanford University, United States

    2 publications · 211 citations

    2

    h-index

  4. NB
    Nageshwar Budha

    University of Tennessee Health Science Center, United States

    2 publications · 211 citations

    2

    h-index

  5. AF
    Adam Frymoyer

    Stanford University, United States

    2 publications · 211 citations

    2

    h-index

1–5 of 193

Institutions

107

  1. AbbVie (United States)

    North Chicago, United States

    3 h-index

    22 publications

    412 citations

  2. Gilead Sciences (United States)

    Foster City, United States

    2 h-index

    15 publications

    361 citations

  3. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    2 publications

    34 citations

  4. University of California, San Francisco

    San Francisco, United States

    2 h-index

    4 publications

    257 citations

  5. Roche (Switzerland)

    Basel, Switzerland

    2 h-index

    12 publications

    384 citations

  6. Stanford University

    Stanford, United States

    2 h-index

    2 publications

    211 citations

  7. Novartis (France)

    Rueil-Malmaison, France

    1 h-index

    8 publications

    88 citations

  8. University of Liverpool

    Liverpool, United Kingdom

    1 h-index

    5 publications

    90 citations

1–8 of 107

Venues

  1. Molecular Pharmaceutics

    4 publications · 290 citations

    4

    h-index

  2. Canadian Journal of Chemistry

    3 publications · 134 citations

    3

    h-index

  3. Journal of The Electrochemical Society

    JES · 1 publications · 35 citations

    1

    h-index

  4. Materials Chemistry and Physics

    1 publications · 17 citations

    1

    h-index

  5. Applied and Environmental Microbiology

    AEM · 1 publications · 24 citations

    1

    h-index

1–5